Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Brilliant Bio Pharma is one of the world’s largest manufacturers of veterinary vaccines—especially foot-and-mouth disease vaccine—and a major supplier to India’s FMD control program. The company has immunized over a billion animals globally with its products. It operates one of the largest BSL3 biomanufacturing facilities for animal vaccines worldwide and maintains a robust R&D pipeline focused on advanced veterinary biologicals. Its portfolio covers bovine, canine, ovine/caprine species with both established and new vaccine candidates under development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brilliant Bio Pharma.